Search

Displaying results 9601 - 9610 of 10000 in total
  1. Drug

    Afizagabar

    go.drugbank.com/drugs/DB21439
    Investigational

    Afizagabar is under investigation in clinical trial NCT02877615 (Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event).

  2. Drug

    Alpha-galactosylceramide

    go.drugbank.com/drugs/DB12232
    Investigational

    KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With

    Synonyms: 1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine
  3. Drug

    Tivanidazole

    go.drugbank.com/drugs/DB20215
    Experimental

    The usage of the INN stem '-nidazole' in the name indicates that Tivanidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.

  4. Drug

    Ternidazole

    go.drugbank.com/drugs/DB19951
    Experimental

    The usage of the INN stem '-nidazole' in the name indicates that Ternidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.

  5. Drug

    Bamnidazole

    go.drugbank.com/drugs/DB19965
    Experimental

    The usage of the INN stem '-nidazole' in the name indicates that Bamnidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.

  6. Drug

    Lificiguat

    go.drugbank.com/drugs/DB19979
    Experimental

    The usage of the INN stem '-ciguat' in the name indicates that Lificiguat is a guanylate cyclase activator and stimulator. Lificiguat has a monoisotopic molecular weight of 304.12 Da.

  7. Drug

    Upleganan

    go.drugbank.com/drugs/DB21618
    Investigational

    Upleganan is under investigation in clinical trial NCT04865393 (Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function).

  8. Drug

    Pocenbrodib

    go.drugbank.com/drugs/DB21616
    Investigational

    Pocenbrodib is under investigation in clinical trial NCT06785636 (Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617).

  9. Drug

    TA-CIN

    go.drugbank.com/drugs/DB05809
    Investigational

    TA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed to generate a strong cellular immune response against HPV-infected cells.

  10. Drug

    Guanosine-5'-Diphosphate

    go.drugbank.com/drugs/DB04315
    Experimental

    A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. [PubChem]